MedPath

Effects of combined treatment of Doxycycline dual with flutamide in female severe acne

Phase 3
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT201104084310N5
Lead Sponsor
Ardabil University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
30
Inclusion Criteria

Inclusion criterion: females with severe acne.
Exclusion criteria: liver disease; pregnancy and breastfeeding; receiving anti acne drug's, OCP and spironolacton in last 2 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in acne leasions. Timepoint: Every two months. Method of measurement: lesions counting.
Secondary Outcome Measures
NameTimeMethod
Patients`satisfaction. Timepoint: Every two months. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath